Annapolis Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Annapolis Ledger.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on November 25, 2025

November 25, 2025

Produxa Releases 2025 Car Detailing Trends as Demand for Fast, At-Home Shine Solutions Surges Nationwide

EIN Presswire

November 25, 2025

Maryland-Based AI Platform Explodes to 3+ Million Students Globally, Earning Coveted Microsoft Partner of the Year Award

EIN Presswire

November 25, 2025

HCIactive Announces Comprehensive AI-Driven Security Modernization Initiative for 2025-2026

EIN Presswire

November 25, 2025

Maryland Physicians Care Extends Planet Fitness Benefit into Carroll County

EIN Presswire

November 25, 2025

Fasoo Enhances Enterprise DRM and DLP Integration to Ensure Continuous Data Protection and Visibility

EIN Presswire

November 25, 2025

MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference

GlobeNewswire

November 25, 2025

Tech Expert Says Starlink’s Global Expansion Marks a Turning Point in Internet History

GlobeNewswire

$NICE Recommends AUCATZYL® (obecabtagene autoleucel) as a Treatment Option for Adult Patients (≥26 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)¹$

November 25, 2025

NICE Recommends AUCATZYL® (obecabtagene autoleucel) as a Treatment Option for Adult Patients (≥26 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)¹

GlobeNewswire

November 25, 2025

Ascentage Pharma Announces Publication of Olverembatinib Phase Ib Safety, Efficacy and Novel Mechanism Data in Gastrointestinal Stromal Tumors in Nature’s Signal Transduction and Targeted Therapy

GlobeNewswire